Definition - What does Invokana mean?
Invokana is a SGLT2 Inhibitor which helps lower blood sugar in patients who suffer from Type II diabetes. Proponents of the medication argue it is a great tool for not only treating diabetes and controlling blood sugar, but doing so without causing hypoglycemia or weight gain.
According to the drug’s developer Janssen Pharmaceuticals, Inc., a part of Johnson & Johnson, Ivokana is a sodium glucose co-transporter 2 (SGLT2) inhibitor which lowers blood sugar and aids with the absorption of glucose into the blood as the blood is filtered by the kidneys. Invokana is revolutionary in that it is able to lower blood sugar more effectively than other diabetic medications such as glimepiride or Amaryl, which heighten insulin production in the pancreas.
Currently, personal injury lawyers are accepting cases from claimants who allege that Janssen, a division of Johnson & Johnson, failed in their duty not only to manufacturer a safe product but also to warn users of the potential side-effects of taking Invokana, including ketoacidosis, heart issues, stroke, and pancreatic or liver disorders.
Justipedia explains Invokana
Users of Invokana, a medication used to treat Type 2 diabetes, report that although this medication may successfully help the kidneys eliminate glucose from the blood, it may also increase the risk of stroke, kidney failure, heart attack, and ketoacidosis (an increased level of acid in the blood).
Not only has the United States Federal Drug and Administration (FDA) issued a warning about the increased risk of ketoacidosis in patients taking Invokana and other SGLT2 inhibitors, according to reports, many patients have suffered medical emergencies after taking these products and had to be hospitalized. In fact, the FDA announced in May of 2015 that more than 20 individuals had suffered diabetic ketoacidosis from Invokana use over the last two years.